Guilin Sanjin Pharmaceutical Co., Ltd.

SZSE:002275 Stock Report

Market Cap: CN¥7.4b

Guilin Sanjin Pharmaceutical Balance Sheet Health

Financial Health criteria checks 5/6

Guilin Sanjin Pharmaceutical has a total shareholder equity of CN¥2.9B and total debt of CN¥375.9M, which brings its debt-to-equity ratio to 12.9%. Its total assets and total liabilities are CN¥3.8B and CN¥898.6M respectively. Guilin Sanjin Pharmaceutical's EBIT is CN¥354.6M making its interest coverage ratio -14.3. It has cash and short-term investments of CN¥1.3B.

Key information

12.9%

Debt to equity ratio

CN¥375.93m

Debt

Interest coverage ratio-14.3x
CashCN¥1.32b
EquityCN¥2.91b
Total liabilitiesCN¥898.60m
Total assetsCN¥3.81b

Recent financial health updates

No updates

Recent updates

Guilin Sanjin Pharmaceutical (SZSE:002275) Is Due To Pay A Dividend Of CN¥0.30

May 23
Guilin Sanjin Pharmaceutical (SZSE:002275) Is Due To Pay A Dividend Of CN¥0.30

Guilin Sanjin Pharmaceutical Co., Ltd.'s (SZSE:002275) Subdued P/E Might Signal An Opportunity

May 22
Guilin Sanjin Pharmaceutical Co., Ltd.'s (SZSE:002275) Subdued P/E Might Signal An Opportunity

Does Guilin Sanjin Pharmaceutical (SZSE:002275) Deserve A Spot On Your Watchlist?

Apr 17
Does Guilin Sanjin Pharmaceutical (SZSE:002275) Deserve A Spot On Your Watchlist?

Financial Position Analysis

Short Term Liabilities: 002275's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥664.9M).

Long Term Liabilities: 002275's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥233.7M).


Debt to Equity History and Analysis

Debt Level: 002275 has more cash than its total debt.

Reducing Debt: 002275's debt to equity ratio has increased from 3.5% to 12.9% over the past 5 years.

Debt Coverage: 002275's debt is well covered by operating cash flow (138.3%).

Interest Coverage: 002275 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.